Nearly 200 Hospital Workers Will Be Fired in Houston If They Don’t Get Vaccinated

Nearly 200 Houston hospital workers will be fired after a two-week suspension if they don’t comply with a vaccine requirement.

Houston Methodist President and CEO Dr. Marc Boom sent an email in April to employees saying that they must receive at least the first dose of the vaccine by June 7, or they would face suspension and termination.

Read More

California Offering Awards Totaling $116.5M to Get Vaxxed

COVID Vaccine sticker

Governor Newsom announced Thursday a $116.5 million vaccine incentive program including $1.5 million in cash prizes to encourage Californians to get the COVID-19 vaccine.

California follows other states in offering big vaccine incentive payouts, New York is giving out scratch-off tickets for the chance to win up to $5 million, according to Politico.

“California has already made incredible progress in the fight against COVID-19, with the lowest case rates in the country while administering millions more vaccines than any other state,” Newsom said in a release. “But we aren’t stopping there, we’re doing everything it takes to get Californians vaccinated as we approach June 15 to help us fully reopen safely.”

Read More

Illegal Immigrants Repeatedly Denied COVID-19 Vaccine in Florida: Report

COVID Vaccine

Undocumented immigrants in Florida have been routinely denied access to the COVID-19 vaccine, the Miami Herald reported Thursday.

A valid Florida driver’s license or government-issued I.D., utility bill or rental agreement is required to receive the vaccine, the Herald reported. Other undocumented immigrants who worked as essential workers across the U.S. haven’t been able to receive the vaccine, though some local governments are advocating for other proofs of residency so they will have access.

“What we feel is that they don’t want immigrants vaccinated,” Doris Mejia, an undocumented immigrant living in Florida told the Herald. “They see us as less, yet we work the most.”

Read More

If a Person Had COVID, One Dose of the Pfizer Vaccine May Be Enough, Studies Suggest

A single dose of Pfizer’s coronavirus vaccine may offer sufficient protection against the virus for people who have already had COVID-19, two studies show.

“This could potentially accelerate vaccine rollout,” researchers at University College of London and Public Health England said in the first study. “With increasing variants, wider coverage without compromising vaccine-induced immunity could help reduce variant emergence.”

Read More

Johnson & Johnson’s Coronavirus Vaccine Offers Strong Protection, Reduces Spread, FDA Analysis Finds

Johnson & Johnson’s one-dose vaccine is effective in preventing severe and fatal coronavirus cases, and may reduce the virus’s transmission among vaccinated people, the FDA said in new analyses Wednesday.

The drug maker announced in January that its vaccine was 72% effective against the virus in the United States and 64% effective in South Africa, where a mutated, more transmissible strain has become dominant. Its vaccine was 86% effective in preventing severe virus cases in the U.S., meaning that a vaccinated individual is at a far smaller risk of being hospitalized or dying from COVID-19.

Read More

Johnson & Johnson Files for Emergency Authorization for Its Coronavirus Vaccine

Johnson & Johnson filed for emergency use authorization from the FDA on Thursday for its coronavirus vaccine.

The drug maker’s application followed its announcement that its vaccine was 72% effective in combating the virus. Although that’s slightly lower than Pfizer and Moderna’s vaccines, Johnson & Johnson’s requires one dose instead of two.

Read More

Johnson & Johnson’s Coronavirus Vaccine Is 72 Percent Effective, But Offers Weaker Protection Against New Strains

Johnson & Johnson announced on Friday that its coronavirus vaccine was 72% effective in combating COVID-19, but only 57% effective against a novel South African strain.

While slightly less effective than Pfizer and Moderna’s vaccines, which were both approved by the FDA in December, Johnson & Johnson’s vaccines provides significant distribution advantages that could be crucial in the nation’s fight against the virus. Unlike Pfizer and Moderna, Pfizer’s vaccine is just one shot, and can be stored in refrigerators instead of freezers.

Read More

Commentary: Five Ways Hospitals Can Help Fix Vaccine Rollout Debacle

Hospitals have come under sharp criticism for their part in the chaotic COVID-19 vaccine rollout. That’s because in the rush to get the vaccine out quickly, many hospitals were shipped more vaccine than anticipated and fewer staff took it than anticipated. As a result, hospitals accrued a vaccine surplus and offered it to their low-risk grad students and young administrative staff working from home and are now scrambling to figure out what to do with the rest. The answer should be simple: give it to older members of your community, but a recent letter from the American Hospital Association cited a number of important barriers to effective vaccine distribution including a lack of coordination and guidance from federal, state, and local governments. 

Read More

Trader Joe’s, Instacart, Dollar General Will Pay Workers to Get Vaccinated

Trader Joe’s is the latest business offering financial incentives to encourage their workers to get the COVID-19 vaccine.

The grocery chain said Thursday it will give employees two hours of pay per dose for getting the vaccine. The Monrovia, California based company said it will also shift around schedules to make sure employees have time to get vaccinated, according USA Today.

Read More

HHS Expected to Recommend Vaccine Distribution Extended to Elderly

The Trump administration is expected to alter its coronavirus vaccine distribution guidance, recommending that people aged 65 and older are made eligible to be inoculated, The New York Times reported.

The Department of Health and Human Services (HHS) and Department of Defense are expected to announce the new guidance at a noon press conference, an anonymous official briefed on the announcement told the Times. The change to the recommendations is intended to quicken the distribution of the coronavirus vaccine, which has been far behind pace.

Read More

Victor Davis Hanson Commentary: If You Thought 2020 Was Hard, Wait Until You Get a Load of 2021

The proper conservative response to last Wednesday’s violent entry into the Capitol and vandalism, as well as assaults on law-enforcement, is to identify the guilty parties and ensure they are arrested.

Such deterrence will prevent any future devolution from legal popular protests into thuggery. No constitutional republic can tolerate its iconic heart stormed, breached, and defiled.

Read More

Pfizer Vaccine Effective Against Contagious Coronavirus Strain, Study Shows

The vaccine developed by Pfizer and BioNTech protects against a highly contagious strain of coronavirus that originated in South Africa and the U.K., according to a study published Thursday.

The study, which was commissioned by Pfizer, is likely to alleviate some fears that the virus variant would evade protections offered by the vaccine.

Read More

Rollout Leaves More Than 70 Percent of COVID-19 Vaccines Unused

More than 70 percent of COVID-19 vaccines have gone unused, still sitting in freezers US health officials said on Monday.

In Daytona Beach, hundreds of senior citizens camped out in their vehicles in chilly overnight temperatures in the low 40s to secure a place in a vaccination line Tuesday morning, a day after seniors jammed the roads to the vaccination site,  NBC Miami reported.

Read More

Millions of COVID-19 Vaccines Have Yet to Be Used Since First U.S. Distribution

Over 9 million COVID-19 vaccines have yet to be administered in the U.S. since they were initially distributed on Dec. 13, according to the Centers for Disease Control and Prevention.

Of the 12,409,050 doses of the vaccines that have been distributed, only 2,794,588 have been administered as of Wednesday morning, according to the Centers for Disease Control and Prevention (CDC).

Read More

CDC Says More Than a Million Americans Have Been Vaccinated for COVID-19

More than a million Americans have received the first round of vaccinations for the coronavirus as of Wednesday at 9 a.m., the Centers for Disease Control and Prevention (CDC) announced.

Over nine million coronavirus doses have been distributed and 1,008,025 doses have been administered, according to the CDC’s COVID Data Tracker.

Read More

BioNTech CEO ‘Confident’ That Coronavirus Vaccine Is Effective Against New European Strain

The CEO of BioNTech, the German drug maker who partnered with Pfizer in developing the world’s first approved coronavirus vaccine, said that he was “confident” it will be effective against a mutated strain of the virus found in the United Kingdom.

“The likelihood that our vaccine works… is relatively high,” Uğur Şahin told reporters during a Tuesday press conference, explaining that the mutated strain still shares approximately 99% of the original strain’s spike protein.

Read More

Pelosi Claims ‘Faith-Oriented’ Lawmakers Say They ‘Don’t Believe in Science’

Democratic Speaker of the House Nancy Pelosi said Monday that “faith-oriented” people in Congress have told her they “don’t believe in science.”

The California Democrat spoke Monday on the house floor where she discussed coronavirus relief and the recently approved vaccines, accusing the White House of spreading “quackery” notions of herd immunity.

Read More

Coronavirus Vaccines Can Guard Against New, More Contagious UK Strain, Experts Say

The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.

Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%.

Read More

FDA Grants Moderna’s Coronavirus Vaccine Emergency Authorization

The FDA approved Moderna’s coronavirus vaccine for emergency use Friday, making the United States the first country to have approved two safe and effective vaccines against COVID-19.

Its approval follows a key FDA panel’s overwhelming vote Thursday to endorse the vaccine’s safety and efficacy. The Moderna vaccine’s approval means that its distribution could begin within hours, providing hospitals and long-term care facilities across the country thousands of much-needed doses.

Read More

US Wants to Double COVID-19 Vaccine Order from Pfizer

Pfizer CEO Albert Bourla said on CNN Monday that the U.S. is seeking to double its COVID-19 vaccine order.

“So far, we have an agreement with the U.S. Government to provide them 100 million doses and this is a fixed order and we will provide those 100 million doses starting from now by the end of the first quarter and we will honor this commitment,” Bourla told CNN Chief Medical Correspondent Dr. Sanjay Gupta on “New Day With Alisyn Camerota and John Berman.”

Read More

More Americans Willing to Take Coronavirus Vaccine After Promising Announcements, Poll Shows

More Americans said that they would receive a coronavirus vaccine when available than they did a month ago, according to a new Gallup poll released Tuesday.

Fifty-eight percent of Americans indicated their willingness to take a vaccine in the poll, which surveyed Americans in late October. That number is up eight percent from Gallup’s previous September poll.

Read More

Commentary: A Vaccine from China? No Thanks

While Democrats including presidential candidate and former Vice President Joe Biden, vice presidential candidate Sen. Kamala Harris (Calif.), House Speaker Nancy Pelosi (Calif.), Senate Minority Leader Chuck Schumer (N.Y.), Gov. Andrew Cuomo (N.Y.), Gov. Gavin Newsom (Calif.), Gov. Ned Lamont (Conn.), and Chicago Mayor Lori Lightfoot all publicly question the Trump administration’s ability to facilitate a safe COVID-19 vaccine, could arsonist-turned-firefighter China have the cure we all need?

Read More

Vaccine Expected to be Ready for Vulnerable Population by January, HHS Sec Azar Says

Department of Health and Human Services Sec. Alex Azar said Wednesday that he expects a coronavirus vaccine to be available for vulnerable Americans by January 2021.

The Health and Human Services (HHS) secretary said that vaccines will be immediately be offered to seniors, health care workers and first responders once hospitals are able to administer it, according to The Hill. Sec. Alex Azar’s comments came at press briefing at the Centers for Disease Control and Prevention headquarters.

Read More

Trump Official Says Vaccine Expected Starting in January

A Trump administration official leading the response to the coronavirus pandemic says the U.S. can expect delivery of a vaccine starting in January 2021, despite statements from the president that inoculations could begin this month.

And a growing, bipartisan chorus of lawmakers, experts and public health officials says the country is ill prepared for a projected winter surge of COVID-19.

Read More

Rob Wittman Discusses the Dragging Feet of Congress and the Mechanics of Operation Warp Speed

Friday morning on The John Fredericks Show, host Fredericks welcomed the U.S. Representative of Virginia’s First District to the show to discuss how Congress is dragging its feet on appropriations bills and the details of a coronavirus vaccine.

Read More

The Status of the Coronavirus Vaccine Continues to Advance Rapidly

Researchers, governments and pharmaceutical companies worldwide have been working rapidly to develop an effective vaccine against coronavirus, which has infected over 4.5 million and killed over 150,000 people in the United States alone.

Testing has advanced quickly and there’s optimism that a vaccine will be developed before 2021. But there are also concerns that a vaccine won’t be sufficiently stockpiled or efficiently distributed. There’s additional worry that the growing distrust in vaccines will result in large numbers refusing the injection, making it less beneficial.

Read More

US Invests Another $2.1 Billion into a Potential Vaccine

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works.

The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery” of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds.

Read More

Commentary: Extraordinary Claims Require Extraordinary Evidence

Dr. Carl Sagan was one of the premier scientists when it came to trying to bridge the gap of hard science with general public understanding. In the process, his personal enthusiasm for the wonder of science became evident to all. He also understood that science could be hijacked and that the highest standards of evidence were required when fantastic claims were being made.

Read More

National Security Adviser ‘Wouldn’t Be Surprised’ if China Steals US Coronavirus Vaccine

by Jason Hopkins   White House National Security Adviser Robert O’Brien on Sunday suggested that the Chinese Community Party would very likely try to steal American developments on a coronavirus vaccine. During an appearance on CBS’s “Face the Nation,” O’Brien predicted that the United States would be the first country…

Read More

Deputy UN Chief: Fight Against Tuberculosis Drastically Underfunded

Tuberculosis (TB) is a vicious epidemic that is drastically underfunded. That was the takeaway message from the first high-level meeting focused on the infectious disease at the U.N. General Assembly in New York. Amina Mohammad, U.N. deputy secretary-general, said the disease is fueled by poverty, inequality, migration and conflict, and…

Read More